Coronary Stent R-Stent Sirolimus drug-eluting is designed for coronary artery lumen expansion and restenosis risk reduction, as well as for treatment of coronary artery lesions with diameters from 2.24 to 4.0 mm.
CLINICAL STUDIES
SPECIFICATIONS
Ultra-low crossing profile (~1.0 mm) of the stent provides improved flexibility and deliverability
Ultra-thin stent strut thickness (65 µm) reduces the risk of late stent thrombosis
Enhanced radial strength of the stent guarantees reliable support of the vessel wall and reduces recoil risk (<5%), ensuring a stable result after implantation
The polymer coating application technology preserves the integrity of the polymer coating after stent expansion and ensures controlled systemic drug release
Thin bioresorbable polymer coating 3 µm thick reduces the risk of vascular inflammation
